FDA Advisory Committee Recommends Approval of Sanofi and Regeneron's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. META
10. AMC

Go back to FDA Advisory Committee Recommends Approval of Sanofi and Regeneron's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia
Regeneron (NASDAQ: REGN) Delayed: 798.17 +13.32 (1.70%)
Previous Close $784.85    52 Week High $592.36 
Open $786.03    52 Week Low $325.35 
Day High $801.44    P/E 209.49 
Day Low $779.96    EPS $3.81 
Volume 704,524       

BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 14.62 +0.31 (2.17%)
Previous Close $14.31    52 Week High $5.58 
Open $14.59    52 Week Low $3.60 
Day High $14.64    P/E N/A 
Day Low $14.53    EPS $0.00 
Volume 11,927,946       

SANOFI (NASDAQ: SNY) Delayed: 42.50 +0.02 (0.05%)
Previous Close $42.48    52 Week High $44.76 
Open $42.64    52 Week Low $36.81 
Day High $42.78    P/E N/A 
Day Low $42.47    EPS $0.00 
Volume 2,484,466